- Conditions
- Amyotrophic Lateral Sclerosis
- Interventions
- Acthar, Placebo
- Drug
- Lead sponsor
- Mallinckrodt
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 143 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2019
- U.S. locations
- 39
- States / cities
- Phoenix, Arizona • Scottsdale, Arizona • La Jolla, California + 33 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 49–72
of 5,269
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Weight Loss, Obesity, Overweight
- Interventions
- ABT Weight Loss Intervention
- Behavioral
- Lead sponsor
- University of Florida
- Other
- Eligibility
- 14 Years to 19 Years · Female only
- Enrollment
- 17 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2020
- U.S. locations
- 1
- States / cities
- Gainesville, Florida
- Conditions
- In-Stent Restenosis, Cardiovascular Diseases, Coronary Artery Disease
- Interventions
- Sirolimus Drug Coated Balloon, Plan balloon Angioplasty (POBA)
- Device
- Lead sponsor
- Concept Medical Inc.
- Industry
- Eligibility
- 18 Years to 110 Years
- Enrollment
- 492 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2028
- U.S. locations
- 27
- States / cities
- Birmingham, Alabama • Gilbert, Arizona • Los Angeles, California + 21 more
- Conditions
- Obesity
- Interventions
- ADAPTIVE Extended-Care Program, STATIC Extended-Care Program
- Behavioral
- Lead sponsor
- University of Florida
- Other
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 255 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2024
- U.S. locations
- 1
- States / cities
- Gainesville, Florida
- Conditions
- Lung Cancer
- Interventions
- celecoxib, radiation therapy
- Drug · Radiation
- Lead sponsor
- Radiation Therapy Oncology Group
- Network
- Eligibility
- 18 Years and older
- Enrollment
- 21 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2002
- U.S. locations
- 44
- States / cities
- Colorado Springs, Colorado • Gainesville, Florida • Jacksonville, Florida + 37 more
- Conditions
- Rhinitis, Allergic, Perennial
- Interventions
- GW685698X
- Drug
- Lead sponsor
- GlaxoSmithKline
- Industry
- Eligibility
- 2 Years to 12 Years
- Enrollment
- 576 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005
- U.S. locations
- 65
- States / cities
- Scottsdale, Arizona • Little Rock, Arkansas • Costa Mesa, California + 58 more
- Conditions
- Aggressive Periodontitis
- Interventions
- Diseased periodontal treatment, Conventional periodontal treatment
- Procedure
- Lead sponsor
- University of Florida
- Other
- Eligibility
- 5 Years to 90 Years
- Enrollment
- 514 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2006 – 2022
- U.S. locations
- 10
- States / cities
- Brooker, Florida • Fort Lauderdale, Florida • Gainesville, Florida + 6 more
- Conditions
- Breast Cancer
- Interventions
- AC regimen, cyclophosphamide, doxorubicin hydrochloride, paclitaxel
- Drug
- Lead sponsor
- Alliance for Clinical Trials in Oncology
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 3,871 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2002 – 2014
- U.S. locations
- 526
- States / cities
- Anniston, Alabama • Birmingham, Alabama • Mobile, Alabama + 359 more
- Conditions
- Necrotizing Enterocolitis, Intra-abdominal Infection
- Interventions
- meropenem
- Drug
- Lead sponsor
- The Emmes Company, LLC
- Industry
- Eligibility
- Up to 90 Days
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2009
- U.S. locations
- 26
- States / cities
- Birmingham, Alabama • Oakland, California • Orange, California + 21 more
- Conditions
- Pancreas Tumor, Pancreatitis
- Interventions
- No Drains, Drains
- Procedure
- Lead sponsor
- Baylor College of Medicine
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 399 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2017
- U.S. locations
- 12
- States / cities
- Gainesville, Florida • Tampa, Florida • Indianapolis, Indiana + 8 more
- Conditions
- Spinal Cord Injuries, Brown Sequard, Central Cord Syndrome
- Interventions
- Intermittent Hypoxia, Locomotor Training
- Other
- Lead sponsor
- VA Office of Research and Development
- Federal
- Eligibility
- 18 Years and older
- Enrollment
- 16 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2014
- U.S. locations
- 1
- States / cities
- Gainesville, Florida
- Conditions
- Head and Neck Cancer, Precancerous Condition
- Interventions
- cetuximab, cisplatin, IMRT
- Biological · Drug · Radiation
- Lead sponsor
- Radiation Therapy Oncology Group
- Network
- Eligibility
- 18 Years to 120 Years
- Enrollment
- 987 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2025
- U.S. locations
- 183
- States / cities
- Anchorage, Alaska • Auburn, California • Burbank, California + 152 more
- Conditions
- Brain Injuries, Traumatic
- Interventions
- Direct-attention training using web-based BrainHQ, Goal Management Training (GMT)
- Behavioral
- Lead sponsor
- VA Office of Research and Development
- Federal
- Eligibility
- 21 Years to 55 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2018
- U.S. locations
- 1
- States / cities
- Gainesville, Florida
- Conditions
- Breast Cancer
- Interventions
- letrozole
- Drug
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Eligibility
- 50 Years and older · Female only
- Enrollment
- 261 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2009
- U.S. locations
- 48
- States / cities
- Huntsville, Alabama • Little Rock, Arkansas • Grass Valley, California + 43 more
- Conditions
- Parkinson's Disease
- Interventions
- High-Frequency Repetitive Transcranial Magnetic Stimulation, Sham Repetitive Transcranial Magnetic Stimulation
- Device
- Lead sponsor
- University of Florida
- Other
- Eligibility
- 30 Years and older
- Enrollment
- 24 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2009
- U.S. locations
- 1
- States / cities
- Gainesville, Florida
- Conditions
- Diverticulitis
- Interventions
- Partial Colectomy, Medical Management
- Procedure · Other
- Lead sponsor
- University of Washington
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 255 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2027
- U.S. locations
- 29
- States / cities
- Los Angeles, California • San Diego, California • San Francisco, California + 24 more
- Conditions
- Acute Coronary Syndrome, High Bleeding Risk
- Interventions
- BioFreedom™ Drug Coated Coronary Stent System, Antiplatelet Drug
- Device · Drug
- Lead sponsor
- Biosensors Europe SA
- Industry
- Eligibility
- Not listed
- Enrollment
- 1,203 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2021
- U.S. locations
- 39
- States / cities
- Huntsville, Alabama • Hot Springs, Arkansas • La Jolla, California + 34 more
- Conditions
- Health, Subjective
- Interventions
- Community health workers (CHW), Educational Materials
- Behavioral
- Lead sponsor
- University of Miami
- Other
- Eligibility
- 13 Years and older
- Enrollment
- 900 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2028
- U.S. locations
- 7
- States / cities
- Gainesville, Florida • Jacksonville, Florida • Miami, Florida + 1 more
- Conditions
- Type 1 Diabetes
- Interventions
- blood draw
- Other
- Lead sponsor
- University of Florida
- Other
- Eligibility
- 0 Years to 100 Years
- Enrollment
- 2,800 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2005 – 2085
- U.S. locations
- 3
- States / cities
- Gainesville, Florida • Columbus, Ohio • Houston, Texas
- Conditions
- Spinal Cord Injury, Spinal Cord Injuries, Trauma, Nervous System, Wounds and Injuries, Central Nervous System Diseases, Nervous System Diseases, Spinal Cord Diseases, Gonadal Disorders, Endocrine System Diseases, Hypogonadism, Genital Diseases, Male
- Interventions
- Testosterone Enanthate, Finasteride, Placebo injection, Placebo pill
- Drug
- Lead sponsor
- VA Office of Research and Development
- Federal
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 33 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2021
- U.S. locations
- 2
- States / cities
- Gainesville, Florida • Tampa, Florida
- Conditions
- Age-Related Macular Degeneration
- Interventions
- POT-4
- Drug
- Lead sponsor
- Potentia Pharmaceuticals, Inc.
- Industry
- Eligibility
- 50 Years and older
- Enrollment
- 27 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2010
- U.S. locations
- 6
- States / cities
- Tucson, Arizona • Beverly Hills, California • Gainesville, Florida + 3 more
- Conditions
- Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythematosus
- Interventions
- Litifilimab, Placebo
- Drug
- Lead sponsor
- Biogen
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 450 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2027
- U.S. locations
- 62
- States / cities
- Anniston, Alabama • Birmingham, Alabama • Phoenix, Arizona + 52 more
- Conditions
- Primary Open-angle Glaucoma, Cataract
- Interventions
- CyPass Micro-Stent implanted with CyPass 241-S applier, Cataract surgery
- Device · Procedure
- Lead sponsor
- Alcon Research
- Industry
- Eligibility
- 45 Years and older
- Enrollment
- 79 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2021
- U.S. locations
- 20
- States / cities
- Phoenix, Arizona • Orange, California • Fort Collins, Colorado + 16 more
- Conditions
- Mitochondrial Function, Physical Function
- Interventions
- Resveratrol 1000 mg/day, Resveratrol 1500 mg/day, Vegetable cellulose, All groups
- Drug · Other
- Lead sponsor
- University of Florida
- Other
- Eligibility
- 65 Years and older
- Enrollment
- 60 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2015 – 2019
- U.S. locations
- 1
- States / cities
- Gainesville, Florida